Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Cellectar Biosciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 40 | 42 | +2 |
| Shares | 7.32M | 6.60M | −726.1K (−9.9%) |
| Value | $6.77M | $4.38M | −$2.40M (−35.4%) |
New holders (10)
Institutions that held Cellectar Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AIGH Capital Management LLC | 896,590 | $596.0K | 0.19% |
| Worth Venture Partners, LLC | 205,675 | $137.0K | 0.07% |
| Citadel Advisors LLC | 164,576 | $109.0K | 0.00% |
| Susquehanna International Group, LLP | 50,256 | $33.0K | 0.00% |
| Virtu Financial LLC | 37,497 | $25.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 20,000 | $13.0K | 0.00% |
| Jane Street Group, LLC | 13,979 | $9.00K | 0.00% |
| Difesa Capital Management, LP | 10,000 | $7.00K | 0.01% |
| Bank of America Corp | 106 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 753 | $0 | 0.00% |
Sold out (8)
Institutions that held Cellectar Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Boxer Capital, LLC | 920,000 | $851.0K |
| Quilter Plc | 17,010 | $16.0K |
| LPL Financial LLC | 14,000 | $13.0K |
| The PNC Financial Services Group, Inc. | 10,000 | $9.00K |
| Advisory Services Network, LLC | 10,000 | $9.00K |
| Tradewinds Capital Management, LLC | 10,000 | $9.00K |
| FMR LLC | 1 | $0 |
| Pacitti Group Inc. | 50 | $0 |